Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1327)
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
10,129
Price
$30.19
Total Value
$305.83K
Shares Held After
25,000
% of Holdings
28.8%
IONIS PHARMACEUTICALS INC (IONS)
Jenne Kyle — EVP, Chf GL Pdt Str Ofcr
Shares
16,086
Price
$76.30
Total Value
$1.23M
Shares Held After
11,714
% of Holdings
57.9%
IONIS PHARMACEUTICALS INC (IONS)
Jenne Kyle — EVP, Chf GL Pdt Str Ofcr
Shares
21,191
Price
$75.50
Total Value
$1.60M
Shares Held After
27,800
% of Holdings
43.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$548.10
Total Value
$65.77K
Shares Held After
130
% of Holdings
48.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$547.14
Total Value
$218.86K
Shares Held After
250
% of Holdings
61.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
480
Price
$546.21
Total Value
$262.18K
Shares Held After
650
% of Holdings
42.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
936
Price
$545.05
Total Value
$510.17K
Shares Held After
1,130
% of Holdings
45.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
824
Price
$544.04
Total Value
$448.29K
Shares Held After
2,066
% of Holdings
28.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
560
Price
$542.88
Total Value
$304.01K
Shares Held After
2,890
% of Holdings
16.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
400
Price
$541.69
Total Value
$216.68K
Shares Held After
3,450
% of Holdings
10.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$540.63
Total Value
$237.88K
Shares Held After
3,850
% of Holdings
10.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,351
Price
$539.84
Total Value
$729.32K
Shares Held After
4,290
% of Holdings
23.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
563
Price
$539.02
Total Value
$303.47K
Shares Held After
5,641
% of Holdings
9.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
647
Price
$537.92
Total Value
$348.04K
Shares Held After
6,204
% of Holdings
9.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
459
Price
$535.99
Total Value
$246.02K
Shares Held After
6,851
% of Holdings
6.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,320
Price
$535.09
Total Value
$706.32K
Shares Held After
7,310
% of Holdings
15.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$533.23
Total Value
$21.33K
Shares Held After
8,630
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$531.54
Total Value
$21.26K
Shares Held After
8,670
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$530.49
Total Value
$63.66K
Shares Held After
8,710
% of Holdings
1.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
800
Price
$530.03
Total Value
$424.02K
Shares Held After
8,830
% of Holdings
8.3%
Entrada Therapeutics, Inc. (TRDA)
Dowden Nathan J — President & COO
Shares
11,894
Price
$13.05
Total Value
$155.19K
Shares Held After
198,588
% of Holdings
5.7%
Fortrea Holdings Inc. (FTRE)
Parks Robert — Chief Accounting Officer
Shares
964
Price
$9.21
Total Value
$8.88K
Shares Held After
22,389
% of Holdings
4.1%
Fortrea Holdings Inc. (FTRE)
Parks Robert — Chief Accounting Officer
Shares
963
Price
$8.93
Total Value
$8.60K
Shares Held After
23,353
% of Holdings
4.0%
Xenon Pharmaceuticals Inc. (XENE)
KENNEY CHRISTOPHER JOHN — Chief Medical Officer
Shares
2,771
Price
$60.11
Total Value
$166.56K
Shares Held After
4,729
% of Holdings
36.9%
Xenon Pharmaceuticals Inc. (XENE)
MORTIMER IAN — Director
Shares
11,269
Price
$60.11
Total Value
$677.36K
Shares Held After
14,731
% of Holdings
43.3%
Xenon Pharmaceuticals Inc. (XENE)
DiFabio Andrea — Chief Legal Officer
Shares
2,607
Price
$60.11
Total Value
$156.70K
Shares Held After
4,893
% of Holdings
34.8%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
500
Price
$15.30
Total Value
$7.65K
Shares Held After
20,406
% of Holdings
2.4%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
500
Price
$15.57
Total Value
$7.78K
Shares Held After
20,906
% of Holdings
2.3%
MiNK Therapeutics, Inc. (INKT)
Ryan Barbara — Director
Shares
300
Price
$15.28
Total Value
$4.58K
Shares Held After
21,406
% of Holdings
1.4%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
4,968
Price
$59.16
Total Value
$293.91K
Shares Held After
166,818
% of Holdings
2.9%
Vaxcyte, Inc. (PCVX)
Wassil Jim — CHIEF OPERATING OFFICER
Shares
2,427
Price
$58.32
Total Value
$141.53K
Shares Held After
171,786
% of Holdings
1.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Caudill Cortney — SVP, CHIEF OPERATING OFFICER
Shares
8,857
Price
$67.64
Total Value
$599.09K
Shares Held After
7,055
% of Holdings
55.7%
MANNKIND CORP (MNKD)
Castagna Michael — Director
Shares
100,000
Price
$2.59
Total Value
$259.00K
Shares Held After
2,575,911
% of Holdings
3.9%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,460
Price
$14.68
Total Value
$285.67K
Shares Held After
643,471
% of Holdings
2.9%
Viking Therapeutics, Inc. (VKTX)
Aubuchon Neil William — Chief Commercial Officer
Shares
4,475
Price
$33.50
Total Value
$149.91K
Shares Held After
4,475
% of Holdings
100.0%
Ultragenyx Pharmaceutical Inc. (RARE)
Parschauer Karah Herdman — EVP and Chief Legal Officer
Shares
3,508
Price
$22.67
Total Value
$79.53K
Shares Held After
66,820
% of Holdings
5.0%
Edesa Biotech, Inc. (EDSA)
Nijhawan Pardeep — Director
Shares
1,000
Price
$6.60
Total Value
$6.60K
Shares Held After
628,813
% of Holdings
0.2%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
17,717
Price
$10.06
Total Value
$178.23K
Shares Held After
231,584
% of Holdings
7.1%
Dyne Therapeutics, Inc. (DYN)
Kersten Dirk — Director
Shares
177,690
Price
$17.72
Total Value
$3.15M
Shares Held After
5,285,156
% of Holdings
3.3%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
1,684
Price
$75.58
Total Value
$127.28K
Shares Held After
242,662
% of Holdings
0.7%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
117,604
Price
$75.26
Total Value
$8.85M
Shares Held After
244,346
% of Holdings
32.5%
IONIS PHARMACEUTICALS INC (IONS)
Monia Brett P — Director
Shares
7,382
Price
$74.11
Total Value
$547.09K
Shares Held After
361,950
% of Holdings
2.0%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Khan Najat — Director
Shares
28,298
Price
$3.35
Total Value
$94.66K
Shares Held After
2,262,085
% of Holdings
1.2%
Bicara Therapeutics Inc. (BCAX)
Mazumdar Claire — Director
Shares
36,766
Price
$19.17
Total Value
$704.66K
Shares Held After
339,392
% of Holdings
9.8%
Entrada Therapeutics, Inc. (TRDA)
WENTWORTH KORY JAMES — Chief Financial Officer
Shares
5,089
Price
$13.00
Total Value
$66.16K
Shares Held After
132,898
% of Holdings
3.7%
Enliven Therapeutics, Inc. (ELVN)
Collins Helen Louise — CHIEF MEDICAL OFFICER
Shares
29,871
Price
$30.02
Total Value
$896.81K
Shares Held After
25,000
% of Holdings
54.4%
Liquidia Corp (LQDA)
Moomaw Scott — Chief Commercial Officer
Shares
80,000
Price
$35.32
Total Value
$2.83M
Shares Held After
188,954
% of Holdings
29.7%
IONIS PHARMACEUTICALS INC (IONS)
O'NEIL PATRICK R. — EVP CLO & General Counsel
Shares
10,148
Price
$75.25
Total Value
$763.66K
Shares Held After
62,211
% of Holdings
14.0%
Kiniksa Pharmaceuticals International, plc (KNSA)
Ragosa Mark — CHIEF FINANCIAL OFFICER
Shares
18,741
Price
$46.24
Total Value
$866.58K
Shares Held After
12,086
% of Holdings
60.8%
Kiniksa Pharmaceuticals International, plc (KNSA)
Ragosa Mark — CHIEF FINANCIAL OFFICER
Shares
17,981
Price
$45.58
Total Value
$819.57K
Shares Held After
30,827
% of Holdings
36.8%
Showing 401–450 of 1327 transactions (page 9 of 27)